The Binaytara Foundation has organized five conferences in September and October, located in three states, Washington, Oregon, and Utah. Most of the conferences are geared toward all oncology medical professionals, with the exception of the Oncology Nursing Summit. Two of the conferences will be held simultaneously at one venue. CME credits will be available for all attendees.
Coming up first is the Cellular Therapy Conference in Salt Lake City, Utah. This conference will feature lectures and discussions from experts in the field of cellular therapies on how CAR techniques can be used to treat patients with cancer and hematologic and non-hematologic disorders.
“The conference agenda includes an in-depth discussion and analysis of the latest scientific findings and practice-changing advances in chimeric antigen receptor (CAR) based therapies. …faculty will aim to place the role of different therapeutic agents in clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care.”Conference overview
Located at the beautiful Salt Lake City Center Hilton, the event will also feature several faculty from the Huntsman Cancer Institute, one of the leading cancer research institutions in the area. 6.75 CME credits will be given to attendees. If you are interested in attending and learning more about cellular therapy, visit the website to sign up.
The Northwest Women’s Cancer Conference is the following weekend, September 17, at the DoubleTree by Hilton in Portland, Oregon. Featured faculty will include experts in breast and gynecologic cancers who will discuss the latest scientific findings and how they can be used to improve patient care. 5.5 CME credits will be available.
The conference overview states, “The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with breast cancer and gynecologic malignancies.”
To participate in this conference, please visit the education portal to sign up.
On October 7-8, the Binaytara Foundation will host the Precision Oncology Conference, also located at the Salt Lake City Center Hilton. The overview describes it as a conference “featuring leading experts in the field of precision oncology who will provide a comprehensive overview of implications of actionable molecular alterations across common malignancies.”
Faculty from around the country will be presenting, with over 100 attendees already registered. 9.5 CME credits will be available. Sign up here!
The Northwest Oncology Nursing Summit, focused on precision oncology, is taking place on October 22, 2022 at the Grand Hyatt in Seattle, WA.
“The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies and solid tumors.”Conference overview
The target audience of this event is more specific, and includes oncology nurses, oncology nurse practitioners, oncology physician assistants, oncology pharmacists, and other healthcare professionals involved in the management of patients with cancer. 6 nursing contact hours/CME credits will be offered. Sign up here!
Lastly, the Seattle Multidisciplinary Thoracic Oncology Conference will be held on October 22, 2022, at the Grand Hyatt Seattle, coinciding with the Nurses Summit. Leading experts in thoracic cancers will present lectures and discussions with a review of the latest advances and questions in the treatment of thoracic cancers.
Faculty from across the country, representing many research institutions, universities, and practices, will be presenting and in attendance. 5.5 CME credits will be available. Register here!
For more information on these conferences, including the agenda, please visit the education portal.
The Binaytara Foundation is a global cancer non-profit dedicated to improving access to cancer care in the United States and abroad through education and innovative program models that break down barriers and advance best practices in hematology and oncology. Binaytara Foundation’s major projects include hematology and oncology conferences, and the establishment of a cancer hospital in Nepal.
2022 Summit on Cancer Health Disparities ASCO award Binaytara foundation Binaytara Foundation Cancer Center Binaytara Foundation education academy breast cancer BTF cancer cancer care cancer disparities cancer research cancer treatment cancer treatment in Nepal CME community oncologists conference Conferences continuing education Dr. Binay Shah Dr. Rubina Suwal events Expert Opinion faculty faculty highlight FDA approved Featured head & neck cancer surgery in Nepal healthcare equity hematological malignancies Journal leukemia Lung cancer lymphoma multiple myeloma Nepal Nepal cancer care oncology oncology CME Opinion peer-reviewed journal SCHD upcoming conferences video news Volunteer
By Dr. Inas Abuali Massachusetts General Hospital There is a paucity of available treatment options for patients with advanced papillary renalMore
On March 4, 2023, the U.S. Food and Drug Administration approved expanded use of adjuvant abemaciclib with endocrine therapy for adult patientsMore
On February 9th, 2023, the U.S. Food and Drug Administration approved dostarlimab-gxly for adult patients with recurrent or advanced endometrial cancer (EC)More
Dr. Daneng Li of City of Hope Comprehensive Cancer Center shares a recent abstract from ASCO GI, NRG/RTOG 1112, a randomized phaseMore
On January 27, 2023, the U.S. Food and Drug Administration approved elacestrant for postmenopausal, non-pregnant women and adult men with advanced orMore